AGMednet Platform Used to Enhance Endpoint Adjudication
Global Clinical Trial Partners (GCTP), a provider of endpoint adjudication services for clinical trials, has chosen AG Mednet’s Judi as its sole technology provider to enhance its services to its clients.
Global Clinical Trial Partners (GCTP), a provider of endpoint adjudication services for clinical trials, clincial trial consultancy servies, and independent adjudication offerings for clinical event committees, has chosen AG Mednet’s Judi as its sole technology provider to enhance its services to its clients.
Judi is an integrated, cloud-based SaaS tool that provides:
- Endpoint data capture via eCRF
- Endpoint process management
- Integration of the CEC process within trial frameworks
- Overall electronic adjudication system development
- Adjudication data packet assembly
Read the full release here.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Phase III SELECT-GCA Trial Results Lead to FDA Approval of Rinvoq for Giant Cell Arteritis
April 30th 2025Rinvoq (upadacitinib) becomes the first oral JAK inhibitor approved by the FDA for the treatment of giant cell arteritis in adults, following robust data from the Phase III SELECT-GCA trial demonstrating its efficacy in achieving sustained remission and reducing glucocorticoid exposure.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
